Home LiteratureArticle Details
PMID: 11121048 Published · ppublish English Journal Article

Genetic restriction of HIV-1 pathogenesis to AIDS by promoter alleles of IL10.

Shin HD, Winkler C, Stephens JC, Bream J, Young H, Goedert JJ, O'Brien TR, Vlahov D, Buchbinder S, Giorgi J, Rinaldo C, Donfield S, Willoughby A, O'Brien SJ, Smith MW

Abstract

IL10 is a powerful TH-2 cell cytokine produced by lymphoid cells that limits HIV-1 replication in vivo, ostensibly by inhibiting macrophage/monocyte and T-cell lymphocyte replication and secretion of inflammatory cytokines (IL1, TNFalpha, IL6, IL8, and IL12). A genetic epidemiological scan of patients enrolled in AIDS cohorts for candidate gene-linked short tandem repeat polymorphisms revealed significant genotype associations for HIV-1 infection and progression to AIDS with markers adjacent to and tracking (by linkage disequilibrium) common single nucleotide polymorphic variants in the IL10 promoter region. Individuals carrying the IL10-5'-592A (IL10-5'A) promoter allele possibly were at increased risk for HIV-1 infection, and once infected they progressed to AIDS more rapidly than homozygotes for the alternative IL10-5'-592 C/C (IL10-+/+) genotype, particularly in the later stages of HIV-1 infection. An estimated 25-30% of long-term nonprogressors (who avoid clinical AIDS for 10 or more years after HIV-1 infection) can be attributed to their IL10-+/+ promoter genotype. Alternative IL10 promoter alleles are functionally distinct in relative IL10 production, in retention of an avian erythroblastosis virus transcription factor recognition sequence and in binding to specific putative nuclear transcription factors, suggesting a potential mechanism whereby IL10-5'A down-regulation of inhibitory IL10 facilitates HIV-1 replication in vivo, accelerating the onset of AIDS.

MeSH Terms
Acquired Immunodeficiency Syndrome/genetics,physiopathology,virology Alleles Disease Progression HIV-1 Humans Interleukin-10/genetics,physiology Microsatellite Repeats Promoter Regions, Genetic
Chemicals
Interleukin-10
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Shin H D
Science Applications International Corporation Frederick, National Cancer Institute, Frederick, MD 21702-1201, USA.
Winkler C
Stephens J C
Bream J
Young H
Goedert J J
O'Brien T R
Vlahov D
Buchbinder S
Giorgi J
Rinaldo C
Donfield S
Willoughby A
O'Brien S J
Smith M W
References (51)
51 references, click to expand
  1. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.
    Science. 1999 Mar 12;283(5408):1748-52 PMID: 10073943
  2. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis.
    Arthritis Rheum. 1999 Jun;42(6):1101-8 PMID: 10366102
  3. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa.
    Hepatology. 1999 Aug;30(2):526-30 PMID: 10421663
  4. The occurrence of lung cancer in man.
    Acta Unio Int Contra Cancrum. 1953;9(3):531-41 PMID: 13124110
  5. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes.
    J Immunol. 1992 Jun 1;148(11):3618-23 PMID: 1350294
  6. The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants.
    NIDA Res Monogr. 1991;109:75-100 PMID: 1661376
  7. IL-10 inhibits cytokine production by activated macrophages.
    J Immunol. 1991 Dec 1;147(11):3815-22 PMID: 1940369
  8. A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia.
    N Engl J Med. 1989 Oct 26;321(17):1141-8 PMID: 2477702
  9. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.
    J Exp Med. 1989 Dec 1;170(6):2081-95 PMID: 2531194
  10. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants.
    Am J Epidemiol. 1987 Aug;126(2):310-8 PMID: 3300281
  11. Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis.
    Nat Genet. 1995 Nov;11(3):325-7 PMID: 7581458
  12. The transmission/disequilibrium test: history, subdivision, and admixture.
    Am J Hum Genet. 1995 Aug;57(2):455-64 PMID: 7668272
  13. Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines.
    Cytokine. 1995 Jan;7(1):1-7 PMID: 7749063
  14. Resistance to HIV-1 infection. Multicenter AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 1994 Dec;7(12):1263-9 PMID: 7965637
  15. Long-term HIV-1 infection without immunologic progression.
    AIDS. 1994 Aug;8(8):1123-8 PMID: 7986410
  16. Hemophilia growth and development study. Design, methods, and entry data.
    Am J Pediatr Hematol Oncol. 1993 May;15(2):208-18 PMID: 8498644
  17. A comprehensive genetic map of the human genome based on 5,264 microsatellites.
    Nature. 1996 Mar 14;380(6570):152-4 PMID: 8600387
  18. Inhibition of acute in vivo human immunodeficiency virus infection by human interleukin 10 treatment of SCID mice implanted with human fetal thymus and liver.
    Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3126-31 PMID: 8610180
  19. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha.
    J Immunol. 1996 Jul 1;157(1):126-37 PMID: 8683106
  20. Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene.
    Nature. 1996 Aug 22;382(6593):722-5 PMID: 8751444
  21. Human immunodeficiency virus type 1 gp120 induces anergy in human peripheral blood lymphocytes by inducing interleukin-10 production.
    J Virol. 1996 Aug;70(8):4953-60 PMID: 8764000
  22. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.
    Science. 1996 Sep 27;273(5283):1856-62 PMID: 8791590
  23. The future of genetic studies of complex human diseases.
    Science. 1996 Sep 13;273(5281):1516-7 PMID: 8801636
  24. Immunological correlates of disease severity in pediatric slow progressors with human immunodeficiency virus type 1 infection.
    AIDS Res Hum Retroviruses. 1996 Jul 20;12(11):1063-8 PMID: 8827222
  25. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression.
    Nat Med. 1996 Nov;2(11):1240-3 PMID: 8898752
  26. Host factors and the pathogenesis of HIV-induced disease.
    Nature. 1996 Dec 12;384(6609):529-34 PMID: 8955267
  27. Cytokine pattern in relation to disease progression in human immunodeficiency virus-infected children.
    J Infect Dis. 1997 Jan;175(1):47-56 PMID: 8985195
  28. Serum interleukin-10 in acquired immunodeficiency syndrome lymphoma patients. Seroco-Hemoco Study Group.
    Eur Cytokine Netw. 1996 Dec;7(4):785-91 PMID: 9010682
  29. Susceptibility to HIV infection and progression of AIDS in relation to variant alleles of mannose-binding lectin.
    Lancet. 1997 Jan 25;349(9047):236-40 PMID: 9014910
  30. Detecting disease-predisposing variants: the haplotype method.
    Am J Hum Genet. 1997 Mar;60(3):703-16 PMID: 9042931
  31. An investigation of polymorphism in the interleukin-10 gene promoter.
    Eur J Immunogenet. 1997 Feb;24(1):1-8 PMID: 9043871
  32. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk.
    Mol Med. 1997 Jan;3(1):23-36 PMID: 9132277
  33. Mapping of the human IL10 gene and further characterization of the 5' flanking sequence.
    Immunogenetics. 1997;46(2):120-8 PMID: 9162098
  34. Linkage study of chromosome 6p in sib-pairs with schizophrenia.
    Am J Med Genet. 1997 May 31;74(3):319-23 PMID: 9184317
  35. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study.
    Science. 1997 Aug 15;277(5328):959-65 PMID: 9252328
  36. In search of AIDS-resistance genes.
    Sci Am. 1997 Sep;277(3):44-51 PMID: 9274039
  37. Host genes and HIV: the role of the chemokine receptor gene CCR5 and its allele.
    Emerg Infect Dis. 1997 Jul-Sep;3(3):261-71 PMID: 9284370
  38. Detection of numerous Y chromosome biallelic polymorphisms by denaturing high-performance liquid chromatography.
    Genome Res. 1997 Oct;7(10):996-1005 PMID: 9331370
  39. CCR2 chemokine receptor and AIDS progression.
    Nat Med. 1997 Oct;3(10):1052-3 PMID: 9334699
  40. Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10).
    Am J Respir Crit Care Med. 1997 Oct;156(4 Pt 2):S152-5 PMID: 9351597
  41. Demographic history and linkage disequilibrium in human populations.
    Nat Genet. 1997 Dec;17(4):435-8 PMID: 9398845
  42. Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL.
    Nucleic Acids Res. 1998 Jan 1;26(1):362-7 PMID: 9399875
  43. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus.
    J Rheumatol. 1997 Dec;24(12):2314-7 PMID: 9415634
  44. Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC)
    Science. 1998 Jan 16;279(5349):389-93 PMID: 9430590
  45. Enhanced interleukin-10 production in response to Mycobacterium avium products in mononuclear cells from patients with human immunodeficiency virus infection.
    J Infect Dis. 1998 Mar;177(3):586-94 PMID: 9498436
  46. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation.
    Nat Med. 1998 Mar;4(3):350-3 PMID: 9500612
  47. Dating the origin of the CCR5-Delta32 AIDS-resistance allele by the coalescence of haplotypes.
    Am J Hum Genet. 1998 Jun;62(6):1507-15 PMID: 9585595
  48. Progression to AIDS.
    Science. 1998 Jun 19;280(5371):1819-20 PMID: 9669928
  49. Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase.
    Am J Hum Genet. 1998 Aug;63(2):595-612 PMID: 9683608
  50. Genetic acceleration of AIDS progression by a promoter variant of CCR5.
    Science. 1998 Dec 4;282(5395):1907-11 PMID: 9836644
  51. Multiple comparison procedures updated.
    Clin Exp Pharmacol Physiol. 1998 Dec;25(12):1032-7 PMID: 9888002
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2000-12-19
Pages
14467-72
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC18942
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com